(KBR) KBR - NYSE
Sector: Industrials | Industry: Engineering & Construction | Exchange: NYSE (USA) | Market Cap: 4.544m USD | Total Return: -33.4% in 12m
Avg Turnover: 53.1M
EPS Trend: 98.6%
Qual. Beats: 3
Rev. Trend: 89.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
KBR, Inc. is a Houston-based provider of scientific, technology, and engineering solutions, primarily serving government agencies and the global energy sector. The company operates through two main segments: Government Solutions and Sustainable Technology Solutions. Its government business focuses on high-end technical services such as cyber analytics, space domain awareness, and advanced prototyping for defense and intelligence missions.
The Sustainable Technology Solutions segment manages a portfolio of proprietary process technologies, specifically targeting ammonia production, petrochemicals, and circular economy initiatives. This business model relies heavily on high-margin intellectual property licensing and long-term engineering contracts aimed at decarbonization and energy transition. Companies in the Research & Consulting Services sub-industry often utilize asset-light models to maintain steady cash flow through professional advisory and technical services.
Investors can further analyze these segment margins and historical performance metrics on ValueRay. KBR’s strategic focus on government contracting provides a degree of insulation from commercial economic cycles due to the long-term nature of defense and space program funding.
- Expansion of high-margin government services contracts increases long-term revenue visibility
- Global demand for ammonia technology drives sustainable technology segment profit growth
- U.S. federal budget appropriations and defense spending levels impact contract backlog
- Adoption of energy transition solutions accelerates proprietary process technology licensing revenue
- International geopolitical instability influences demand for mission-critical government support services
| Net Income: 401.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.26 > 1.0 |
| NWC/Revenue: 3.42% < 20% (prev 2.51%; Δ 0.91% < -1%) |
| CFO/TA 0.08 > 3% & CFO 534.0m > Net Income 401.0m |
| Net Debt (2.72b) to EBITDA (927.0m): 2.93 < 3 |
| Current Ratio: 1.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.0m) vs 12m ago -3.79% < -2% |
| Gross Margin: 14.50% > 18% (prev 14.45%; Δ 0.05% > 0.5%) |
| Asset Turnover: 114.2% > 50% (prev 116.4%; Δ -2.24% > 0%) |
| Interest Coverage Ratio: 4.59 > 6 (EBIT TTM 758.0m / Interest Expense TTM 165.0m) |
| A: 0.04 (Total Current Assets 1.95b - Total Current Liabilities 1.68b) / Total Assets 6.62b |
| B: 0.27 (Retained Earnings 1.78b / Total Assets 6.62b) |
| C: 0.11 (EBIT TTM 758.0m / Avg Total Assets 6.74b) |
| D: 0.31 (Book Value of Equity 1.58b / Total Liabilities 5.04b) |
| Altman-Z'' = 2.22 = BBB |
| DSRI: 0.99 (Receivables 1.37b/1.43b, Revenue 7.69b/7.97b) |
| GMI: 1.00 (GM 14.45% / 14.50%) |
| AQI: 1.02 (AQ_t 0.64 / AQ_t-1 0.63) |
| SGI: 0.96 (Revenue 7.69b / 7.97b) |
| TATA: -0.02 (NI 401.0m - CFO 534.0m) / TA 6.62b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of June 16, 2026, the stock is trading at USD 34.82 with a total of 1,499,657 shares traded.
Over the past week, the price has changed by -0.65%,
over one month by +16.37%,
over three months by -4.32% and
over the past year by -33.36%.
KBR has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy KBR.
- StrongBuy: 4
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 46.6 | 33.7% |
P/E Trailing = 10.5723
P/E Forward = 8.8106
P/S = 0.5908
P/B = 2.8304
P/EG = 0.5338
Revenue TTM = 7.69b USD
EBIT TTM = 758.0m USD
EBITDA TTM = 927.0m USD
Long Term Debt = 2.53b USD (from longTermDebt, last quarter)
Short Term Debt = 49.0m USD (from shortTermDebt, last quarter)
Debt = 3.04b USD (from shortLongTermDebtTotal, last quarter) + Leases 228.0m
Net Debt = 2.72b USD (calculated: Debt 3.04b - CCE 321.0m)
Enterprise Value = 7.26b USD (4.54b + Debt 3.04b - CCE 321.0m)
Interest Coverage Ratio = 4.59 (Ebit TTM 758.0m / Interest Expense TTM 165.0m)
EV/FCF = 14.85x (Enterprise Value 7.26b / FCF TTM 489.0m)
FCF Yield = 6.73% (FCF TTM 489.0m / Enterprise Value 7.26b)
FCF Margin = 6.36% (FCF TTM 489.0m / Revenue TTM 7.69b)
Net Margin = 5.21% (Net Income TTM 401.0m / Revenue TTM 7.69b)
Gross Margin = 14.50% ((Revenue TTM 7.69b - Cost of Revenue TTM 6.58b) / Revenue TTM)
Gross Margin QoQ = 13.78% (prev 15.38%)
Tobins Q-Ratio = 1.10 (Enterprise Value 7.26b / Total Assets 6.62b)
Interest Expense / Debt = 5.43% (Interest Expense 165.0m / Debt 3.04b)
Taxrate = 25.80% (153.0m / 593.0m)
NOPAT = 562.4m (EBIT 758.0m * (1 - 25.80%))
Current Ratio = 1.16 (Total Current Assets 1.95b / Total Current Liabilities 1.68b)
Debt / Equity = 1.92 (Debt 3.04b / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 2.93 (Net Debt 2.72b / EBITDA 927.0m)
Debt / FCF = 5.56 (Net Debt 2.72b / FCF TTM 489.0m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.95% (Net Income 401.0m / Total Assets 6.62b)
RoE = 26.57% (Net Income TTM 401.0m / Total Stockholder Equity 1.51b)
RoCE = 18.75% (EBIT 758.0m / Capital Employed (Equity 1.51b + L.T.Debt 2.53b))
RoIC = 12.05% (NOPAT 562.4m / Invested Capital 4.67b)
WACC = 6.31% (E(4.54b)/V(7.58b) * Re(7.84%) + D(3.04b)/V(7.58b) * Rd(5.43%) * (1-Tc(0.26)))
Discount Rate = 7.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.21 | Cagr: -2.70%
[DCF] Terminal Value 77.97% ; FCFF base≈461.0m ; Y1≈528.5m ; Y5≈777.8m
[DCF] Fair Price = 70.87 (EV 11.7b - Net Debt 2.72b = Equity 8.99b / Shares 126.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.56 | EPS CAGR: 15.42% | SUE: 1.30 | # QB: 3
Revenue Correlation: 89.89 | Revenue CAGR: 6.97% | SUE: 0.63 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.90 | Chg30d=-2.51% | Revisions=-40% | Analysts=8
EPS next Quarter (2026-09-30): EPS=1.03 | Chg30d=-1.39% | Revisions=+0% | Analysts=8
EPS current Year (2026-12-31): EPS=3.96 | Chg30d=-0.52% | Revisions=+8% | GrowthEPS=+0.8% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=4.15 | Chg30d=-1.27% | Revisions=-8% | GrowthEPS=+4.7% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: -40%